Endocrine Disruptor assessment for (3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one concluded

Europe
Written by Cathrin Cailliau

On 12 April 2023, an assessment for the following substance on ECHA's Endocrine Disruptor Assessment List concluded:

  1. (3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one

Cathrin Cailliau
Previous

Final IRIS Assessment published
Next

PACT updated with 1 finalised Hazard assessment